Healthtech Startups
15,468 companies tagged Healthtech, with their investors and founders.
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure. The technology is used by neurosurgeons and clinical teams to perform precision, real-time monitored brain treatments.
7 investors
IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities. The platform helps healthcare organizations fill staffing needs while enabling nurses to find work opportunities that align with their lifestyle preferences.
7 investors
Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
7 investors
Johnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
7 investors
Jutro Medical operates primary care clinics (POZ) in Poland offering telemedicine and in-person visits under the public NFZ system, with an app for booking appointments and accessing prescriptions, test results, and recommendations. It serves patients across Poland with same-day remote consultations, e-prescriptions, and physical clinics in cities including Warsaw, PoznaΕ, Katowice, and BiaΕystok.
7 investors
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
7 investors
Kheiron Medical Technologies developed AI-powered breast cancer diagnostic tools, including Miaβ’, which assisted radiologists in breast screening decision-making. The company was acquired by DeepHealth in 2024 and its technology now supports SmartMammoβ’, an AI solution for breast cancer diagnostic workflows.
7 investors
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases. It uses AAV-mediated gene therapy approaches across metabolic, neurodegenerative, and other disease areas.
7 investors
Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices. The company serves healthcare providers and patients requiring faster, more accessible diagnostic solutions.
7 investors
Luminai builds an AI-native operating system that unifies fragmented healthcare operational work streams to automate administrative and operational tasks across health systems. The platform addresses the rising cost of healthcare administration by automating interconnected work processes that previously required point solutions and large workforces.
7 investors
Coroyawa is a specialized flooring material designed to reduce fracture and trauma risk for elderly users by combining stable walking comfort with impact absorption during falls. The product uses mechanical metamaterial technology to remain firm during normal walking while deforming to absorb shock upon impact, targeting hospitals and care facilities in Japan.
7 investors
Magical provides workflow automation software that uses AI to eliminate repetitive manual tasks for enterprise teams. The platform automates business processes across various workflows and departments.
7 investors
Mercy develops blood-based tests for early cancer detection using its patented Mercy Halo platform, which applies qPCR technology and extracellular vesicles to identify combinations of cancer-associated biomarkers. The company aims to provide low-cost, broadly accessible diagnostics that detect cancer at its earliest, most treatable stages.
7 investors
Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG). It uses a "search & development" strategy to identify and advance drug programs for specific patient populations.
7 investors
MinervaX is a clinical-stage biotech company developing a prophylactic vaccine against Group B Streptococcus, with a lead candidate (AlpN GBS) in clinical trials for use in pregnancy and older adults. Its vaccine aims to prevent adverse pregnancy outcomes and life-threatening infections caused by Group B Streptococcus.
7 investors
Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome. Its lead candidate, leriglitazone, is being evaluated in clinical trials and regulatory review for these rare CNS conditions.
7 investors
Monument is a telehealth platform offering video appointments with doctors and therapists for both medical and mental healthcare, with prescriptions sent to a patient's preferred pharmacy. It accepts most health insurance plans and lets patients build ongoing relationships with the same care team through one-time or recurring visits.
7 investors
Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain. The system consists of an implanted microstimulator, a separate electrode array, and an externally worn, battery-free therapy disc, offered as a drug-free treatment option to patients through their doctors.
7 investors
NOCD provides specialized treatment for obsessive-compulsive disorder through live video sessions with OCD-trained therapists and 24/7 in-app support between sessions, using exposure and response prevention (ERP) therapy. The service is delivered virtually via the NOCD app and is covered by more than 70 insurance plans.
7 investors
Noyo builds APIs and infrastructure that connect and standardize benefits data, enabling modern benefits experiences to be embedded into software. It serves benefits technology providers and the health/employee benefits industry.
7 investors
Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.
7 investors
ODAIA offers Marketing Intelligence, a platform for pharmaceutical marketing and sales teams that ties channel-level actions to prescription (Rx) outcomes and coordinates healthcare provider (HCP) engagement across digital and field channels. It uses attribution and sequencing engines to measure script lift and ROI per channel and recommend campaign messages and timing.
7 investors
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness. Its lead candidate, xelafaslatide (formerly ONL1204), is a first-in-class small peptide targeting Fas-mediated signaling across multiple eye diseases.
7 investors
Orion Sleep develops smart sleep technology, including sensors and covers, to make world-class sleep science accessible and affordable for consumers.
7 investors